CZMWY (Carl Zeiss Meditec AG) Debt-to-Equity : 0.07 (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Carl Zeiss Meditec AG Debt-to-Equity?

Carl Zeiss Meditec AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $27 Mil. Carl Zeiss Meditec AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $141 Mil. Carl Zeiss Meditec AG's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $2,266 Mil. Carl Zeiss Meditec AG's debt to equity for the quarter that ended in Sep. 2024 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Carl Zeiss Meditec AG's Debt-to-Equity or its related term are showing as below:

CZMWY' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.11
Current: 0.07

During the past 13 years, the highest Debt-to-Equity Ratio of Carl Zeiss Meditec AG was 0.11. The lowest was 0.00. And the median was 0.02.

CZMWY's Debt-to-Equity is ranked better than
76.28% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs CZMWY: 0.07

Carl Zeiss Meditec AG Debt-to-Equity Historical Data

The historical data trend for Carl Zeiss Meditec AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Debt-to-Equity Chart

Carl Zeiss Meditec AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Debt-to-Equity

Get a 7-Day Free Trial

0.05

0.07

0.06

0.07

Carl Zeiss Meditec AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.07	N/A	0.07	N/A	0.07

Competitive Comparison of Carl Zeiss Meditec AG's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Debt-to-Equity falls into.

Carl Zeiss Meditec AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Carl Zeiss Meditec AG's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27.292	+	140.685)	/	2266.034
	=	0.07

Carl Zeiss Meditec AG's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27.292	+	140.685)	/	2266.034
	=	0.07

Carl Zeiss Meditec AG (OTCPK:CZMWY) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Carl Zeiss Meditec AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWY) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CZMWF:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Austria

Address

Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745

Website

https://www.zeiss.com

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.